XT
BBOT

XTX Topco’s BridgeBio Oncology BBOT Stock Holding History

XTX Topco’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$535K Buy
59,743
+31,110
+109% +$334K 0.01% 1989
2025
Q4 		$358K Buy
28,633
+5,249
+22% +$63.6K 0.01% 1911
2025
Q3 		$271K Buy
+23,384
New +$244K 0.01% 1586

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco's BBOT Position: Q1 2026 in Review

XTX Topco increased its BridgeBio Oncology (BBOT) stake by 109% in Q1 2026, buying an estimated $334K and bringing the position to 59,743 shares worth $535K. The position accounts for 0.01% of the portfolio, ranked #1989.

XTX Topco first reported a position in BBOT in Q3 2025 and has held it in 3 quarters since. 67 funds tracked by Wall St. Rank hold BBOT as of Q1 2026.

  • XTX Topco held 59,743 shares of BridgeBio Oncology worth $535K as of Q1 2026.
  • XTX Topco bought 31,110 BridgeBio Oncology shares in Q1 2026, an estimated $334K.
  • BridgeBio Oncology made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1989 holding.
  • XTX Topco first reported a position in BridgeBio Oncology in Q3 2025 and has held it in 3 quarters since.
  • 67 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.